1985607-83-7 Usage
General Description
Zofluza intermediate refers to an intermediate substance used in the preparation of Zofluza, a prescription medicine used to treat influenza in individuals above the age of 12. Zofluza (otherwise known as Baloxavir Marboxil) works by inhibiting the replication of the influenza virus within the body, thereby easing symptoms and reducing the duration of the illness. The exact chemical structure or process involving the Zofluza intermediate isn't publicly disclosed due to the proprietary nature of pharmaceutical manufacturing. Like many pharmaceutical intermediates, they are valuable for fine-tuning chemical reactions to produce the final active pharmaceutical ingredient (API).
Check Digit Verification of cas no
The CAS Registry Mumber 1985607-83-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,9,8,5,6,0 and 7 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1985607-83:
(9*1)+(8*9)+(7*8)+(6*5)+(5*6)+(4*0)+(3*7)+(2*8)+(1*3)=237
237 % 10 = 7
So 1985607-83-7 is a valid CAS Registry Number.
1985607-83-7Relevant articles and documents
Pyridazone derivative and its uses
-
Paragraph 0163, (2022/01/12)
The present invention belongs to the pharmaceutical field, specifically relates to a pyridazone derivative and its uses, compounds thereof and pharmaceutically acceptable salts, solvates including hydrates, polycrystallines, prodrugs, co-crystallines, tau
Preparation method of sulfur-containing hetero-seven-membered ring compound
-
, (2021/06/13)
The invention relates to a preparation method of a sulfur-containing hetero-seven-membered ring compound. The method comprises the following steps: carrying out halogenation reaction, nucleophilic substitution, acylation, cyclization, reduction and the li
Pyridone-containing polycyclic derivative inhibitor as well as preparation method and application thereof
-
Paragraph 0163; 0210-0213, (2021/05/12)
The invention relates to a pyridone-containing polycyclic derivative inhibitor as well as a preparation method and an application thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation method
